Is Trevi Therapeutics Inc (NASDAQ:TRVI), -55.04% Below Its High, Poised For A Strong Recovery?
In last trading session, Trevi Therapeutics Inc (NASDAQ:TRVI) saw 64317.0 shares changing hands with its beta currently measuring 1.01. Company’s recent per share price level